Form 4: Bone Biologics Director Receives Stock Grant
Insider Transaction (Form 4)
Phillip Terry Meikle Ii, a Director of Bone Biologics Corp, received 113,896 shares of common stock on September 28, 2026.
Summary
- Grant/award: acquired 113,896 Non-Employee Stock Option on September 28, 2026; holds 113,896 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Phillip Terry Meikle Ii — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-28 | Grant/award | Non-Employee Stock Option | 113,896 | — | — | 113,896 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-28 | Grant/award (113,896 shares) |
Keywords
insider transaction, Form 4, BBLG, Bone Biologics Corp, neutral, Phillip Terry Meikle Ii
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.